Quick Takeaways
- IMDX - Insight Molecular Diagnostics Inc. has 21 insiders with reported activity on this page.
- Net insider value flow over the last year: +$2,999,999.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 21 Insiders of Insight Molecular Diagnostics Inc.
- Symbol
- IMDX on Nasdaq
- Location
- Nashville, TN
What Changed
- Buy value: $2,999,999; sell value: $0.
- Net share flow: +521,739.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$2,999,999.
Buys
$2,999,999
Shares: 521,739
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$2,999,999
Shares: +521,739
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 521,739 | 0 | $2,999,999 | $0 | +$2,999,999 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Insight Molecular Diagnostics Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10%+ Owner | $160,348,260 | +$2,999,999 | +1.9% | Mixed | 10 Feb 2026 |
| Patrick W. Smith | 10%+ Owner | $6,679,894 | Mixed | 07 Feb 2025 | ||
| PURA VIDA INVESTMENTS, LLC | 10%+ Owner | $3,044,309 | Mixed | 14 Apr 2023 | ||
| Andrea S. James | Chief Financial Officer | $1,777,524 | Mixed | 26 Mar 2026 | ||
| Josh Riggs | CEO and President, Director | $674,529 | Mixed | 26 Mar 2026 | ||
| Andrew Arno | Director | $381,104 | Mixed | 01 Jul 2025 | ||
| John Peter Gutfreund | Former Director | $153,654 | Mixed | 30 Jun 2023 | ||
| Ronald Asbury Andrews | Former CEO, Director | $125,332 | Mixed | 01 Dec 2022 | ||
| Alfred D. Kingsley | Director | $109,143 | Mixed | 23 Jun 2023 | ||
| Andrew J. Last | Director | $104,303 | Mixed | 01 Jul 2025 | ||
| Lou Silverman | Director | $96,528 | Mixed | 01 Jul 2025 | ||
| Gisela Paulsen | Former President and COO | $78,761 | Mixed | 16 Dec 2022 | ||
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | $76,536 | Mixed | 18 May 2022 | ||
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | $66,509 | Mixed | 26 Mar 2026 | ||
| Ross Douglas T. | Former CSO | $50,311 | Mixed | 21 Dec 2022 | ||
| Cavan M. Redmond | Director | $25,973 | Mixed | 24 Jun 2022 | ||
| Mitchell S. Levine | Chief Financial Officer | $18,713 | Mixed | 15 Mar 2022 | ||
| Jennifer Levin Carter | Director | $6,554 | Mixed | 15 Aug 2022 | ||
| Melinda Griffith | Director | $6,447 | Mixed | 15 Aug 2022 | ||
| Anish M. John | Chief Financial Officer | Mixed | 24 Feb 2023 | |||
| Padmavathi Sundar | Chief Commercial Officer | Mixed | 15 Mar 2022 |
Top shareholders of Insight Molecular Diagnostics Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. |
3/4/5
13D/G
|
10%+ Owner · Neal C. Bradsher |
37%
from 13D/G
|
24,163,864
mixed-class rows
|
$160,348,260 | +$2,999,999 | 10 Feb 2026 | |
| BROADWOOD CAPITAL INC |
13F
|
Company |
35%
|
11,410,100
|
$85,575,750 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
2,814,230
|
$21,106,725 | — | 31 Dec 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
2.9%
|
947,134
|
$7,103,505 | — | 31 Dec 2025 | |
| Patrick W. Smith |
3/4/5
13D/G
|
10%+ Owner |
10%
from 13D/G
|
3,258,485
|
$6,679,894 | — | 07 Feb 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
526,675
|
$3,950,064 | — | 31 Dec 2025 | |
| Andrea S. James |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
525,965
mixed-class rows
|
$1,777,524 | — | 26 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
230,971
|
$1,733,670 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.41%
|
131,361
|
$985,208 | — | 31 Dec 2025 | |
| Josh Riggs |
3/4/5
|
CEO and President, Director |
—
mixed-class rows
|
579,874
mixed-class rows
|
$674,529 | — | 26 Mar 2026 | |
| BIO-RAD LABORATORIES, INC. |
13D/G
|
— |
9.7%
|
2,764,078
|
$608,097 | $0 | 10 Feb 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.24%
|
77,204
|
$579,030 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
72,451
|
$543,383 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
61,377
|
$460,328 | — | 31 Dec 2025 | |
| Andrew Arno |
3/4/5
|
Director |
—
mixed-class rows
|
174,358
mixed-class rows
|
$381,104 | — | 01 Jul 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
48,858
|
$366,435 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
47,754
|
$358,155 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.13%
|
42,469
|
$318,517 | — | 31 Dec 2025 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.13%
|
40,584
|
$304,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
35,913
|
$269,348 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.09%
|
28,351
|
$212,633 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.08%
|
26,164
|
$196,230 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.07%
|
24,136
|
$181,019 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
23,965
|
$179,738 | — | 31 Dec 2025 | |
| John Peter Gutfreund |
3/4/5
|
Former Director |
—
mixed-class rows
|
760,000
mixed-class rows
|
$153,654 | — | 30 Jun 2023 | |
| Ronald Asbury Andrews |
3/4/5
|
Former CEO, Director |
—
mixed-class rows
|
633,212
mixed-class rows
|
$125,332 | — | 01 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
15,647
|
$117,353 | — | 31 Dec 2025 | |
| Alfred D. Kingsley |
3/4/5
|
Director |
—
mixed-class rows
|
597,878
mixed-class rows
|
$109,143 | — | 23 Jun 2023 | |
| Andrew J. Last |
3/4/5
|
Director |
—
mixed-class rows
|
69,509
mixed-class rows
|
$104,303 | — | 01 Jul 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
13,400
|
$100,500 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.04%
|
13,061
|
$97,958 | — | 31 Dec 2025 | |
| Lou Silverman |
3/4/5
|
Director |
—
mixed-class rows
|
66,564
mixed-class rows
|
$96,528 | — | 01 Jul 2025 | |
| Gisela Paulsen |
3/4/5
|
Former President and COO |
—
class O/S missing
|
366,500
|
$78,761 | — | 16 Dec 2022 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.03%
|
10,416
|
$78,120 | — | 31 Dec 2025 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| James Yang Liu |
3/4/5
|
VP ACCT, Cntlr, Treasurer, PAO |
—
mixed-class rows
|
34,289
mixed-class rows
|
$66,509 | — | 26 Mar 2026 | |
| Ross Douglas T. |
3/4/5
|
Former CSO |
—
class O/S missing
|
234,114
|
$50,311 | — | 21 Dec 2022 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0.02%
|
5,000
|
$37,500 | — | 31 Dec 2025 | |
| Cavan M. Redmond |
3/4/5
|
Director |
—
class O/S missing
|
120,863
|
$25,973 | — | 24 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,941
|
$22,058 | — | 31 Dec 2025 | |
| Mitchell S. Levine |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
174,580
mixed-class rows
|
$18,713 | — | 15 Mar 2022 | |
| Jennifer Levin Carter |
3/4/5
|
Director |
—
mixed-class rows
|
75,500
mixed-class rows
|
$6,554 | — | 15 Aug 2022 | |
| Melinda Griffith |
3/4/5
|
Director |
—
mixed-class rows
|
75,000
mixed-class rows
|
$6,447 | — | 15 Aug 2022 | |
| ORG Partners LLC |
13F
|
Company |
0%
|
450
|
$3,375 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
335
|
$2,513 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
250
|
$1,875 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
185
|
$1,388 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
154
|
$1,155 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
30
|
$225 | — | 31 Dec 2025 | |
| Piscataqua Savings Bank |
13F
|
Company |
0%
|
25
|
$187 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Insight Molecular Diagnostics Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrea S. James | IMDX | Common Stock | Tax liability | -5.2% | -11,298 | 206,060 | 26 Mar 2026 | Direct | ||
| Andrea S. James | IMDX | Common Stock | Options Exercise | 15% | 28,302 | 217,358 | 26 Mar 2026 | Direct | ||
| Andrea S. James | IMDX | Restricted Stock Units | Options Exercise | -25% | -28,302 | 84,905 | 26 Mar 2026 | Direct | ||
| James Yang Liu | IMDX | Common Stock | Tax liability | -41% | -2,578 | 3,711 | 26 Mar 2026 | Direct | ||
| James Yang Liu | IMDX | Common Stock | Options Exercise | 6,289 | 6,289 | 26 Mar 2026 | Direct | |||
| James Yang Liu | IMDX | Restricted Stock Units | Options Exercise | -33.3% | -6,289 | 12,578 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Common Stock | Tax liability | -24.3% | -12,310 | 38,365 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Common Stock | Options Exercise | 1345.8% | 47,170 | 50,675 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Restricted Stock Units | Options Exercise | -25% | -47,170 | 141,509 | 26 Mar 2026 | Direct | ||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 11,931,839 | 10 Feb 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 4.57% | $2,999,999 | $5.75 | 521,739 | 11,931,839 | 10 Feb 2026 | Direct |
| Andrea S. James | OCX | Common Stock | Tax liability | -6.05% | -12,175 | 189,056 | 31 Oct 2025 | Direct | ||
| Andrea S. James | OCX | Common Stock | Options Exercise | 33.1% | 50,000 | 201,231 | 31 Oct 2025 | Direct | ||
| Andrea S. James | OCX | Restricted Stock Units | Options Exercise | -50% | -50,000 | 50,000 | 31 Oct 2025 | Direct | ||
| James Yang Liu | OCX | Option to Purchase Common Stock | Award | 18,000 | 18,000 | 28 Sep 2025 | Direct | |||
| Andrea S. James | OCX | Option to Purchase Common Stock | Award | 235,000 | 235,000 | 28 Sep 2025 | Direct | |||
| Josh Riggs | OCX | Option to Purchase Common Stock | Award | 400,000 | 400,000 | 28 Sep 2025 | Direct | |||
| Lou Silverman | OCX | Common Stock, no par value | Award | 2237.8% | 35,000 | 36,564 | 01 Jul 2025 | Direct | ||
| Andrew Arno | OCX | Common Stock, no par value | Award | 67.4% | 55,000 | 136,554 | 01 Jul 2025 | Direct | ||
| Andrew J. Last | OCX | Common Stock, no par value | Award | 776.2% | 35,000 | 39,509 | 01 Jul 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.